To access this material please log in or register

Register Authorize

Evaluation of quality of life in patients with ischemic heart disease associated with atrial fibrillation after radiofrequency ablation of anatomical areas in left atrial ganglionic plexi

Chernyavsky A. M., Rakhmonov S. S., Pak I. A., Kareva Yu. E.
Federal State Budgetary Institution, “Academician E. N. Meshalkin Novosibirsk Research Institute of Circulatory Pathology” of the RF Ministry of Health Care, Rechkunovskaya 15, Novosibirsk 630055

Keywords: quality of life, coronary heart disease, atrial fibrillation, treatment

DOI: 10.18087/rhj.2015.4.2078

Background. Atrial fibrillation (AF) is the most common, stable disorder of heart rhythm. AF is known to be often associated with palpitation, dizziness, reduced exercise tolerance, shortness of breath and other symptoms affecting the tolerability of disease. Quality of life (QoL) indices are an instrument for evaluation of symptom severity and treatment effectiveness. Aim. To study changes in QoL following coronary bypass and radiofrequency ablation of anatomical areas in left ventricular ganglionic plexi in IHD patients with AF. Materials and methods. The study included 92 patients. Based on the AF form, the patients were randomized to three groups. Group I consisted of patients with paroxysmal AF; group II – patients with persistent AF; and group III – patients with long-lasting, persistent AF. QoL parameters were evaluated using a non-specific questionnaire, SF-36. The questionnaire was completed at the preoperative stage and during the remote postoperative period (12–24 months). Results. During the remote postoperative period, all groups showed significant improvements in most of parameters characterizing both physical and mental health components. Conclusion. Reversing angina symptoms and long-term maintenance of regular heart rhythm provide improvement of QoL in the postoperative period.
  1. Дедов Д. В., Иванов А. П., Эльгард И. А. Риск рецидива фибрилляции предсердий у больных ишемической болезнью сердца и артериальной гипертензией по данным Холтеровского мониторирования электрокардиограммы. Вестник аритмологии. 2010; 59: 27–32.
  2. Go AS, Hylek EM, Phillips KA, et al. Prevalence of Diagnosed Atrial Fibrillation in Adults: National Implications for Rhythm Management and Stroke Prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285: 2370–2375.
  3. Андреева Г. Ф. Изучение качества жизни у больных гипертонической болезнью. Терапевт, арх. 2002;1: 8–16.
  4. Померанцевой В. П. Качество жизни у больных инфарктом миокарда. Кардиология. 1996; 3: 70–74.
  5. Reynolds M. R., Ellis E., Zimetbaum M. D. et al. Quality of Life in Atrial Fibrillation: Measurement and Impact of Interventions. Journal of Cardiovascular Electrophysiology. 2008; 19 (7): 762–768.
  6. Dorian P., Cvitkovic S. S., Kerr C. R., et al. A novel, simple scale for assessing the symptom severity of artrial fi brillation at the bedside: The CCS SAF scale. Can. J. Cardiol. 2006; 22: 383–386.
  7. Van den Berg M., Hassink R. J., Tuinenburg A. E. et al. Quality of life in patients with paroxysmal atrial fibrillation and its predictors: importance of the autonomic nervous system. Eur. Heart J. 2001; 22: 247–253.
  8. Петрова М. М. Качество жизни у мужчин, перенесших инфаркт миокарда. Кардиология. 2000; 2: 65–66.
  9. Егоров Д. Ф. Мерцательная аритмия: стратегия и тактика на пороге XXI века. СПб., «Алфавит», 1998. – 13–18 c.
  10. Кушаковский М. С. Аритмии сердца. СПб., 1999. – 35-41с.
  11. Сыркин А. Л. Определение качества жизни у больных ИБС стабильной стенокардией напряжения. Клин. медицина.1998; 6: 52–58.
  12. Rector T. S. Effect of ACE inhibitors on the quality of life of patients with heart failure. Coronary Artery Dis. 1995; 6 (4): 310–314.
  13. Carney R. M. Depression and coronary heart disease a review for cardiologists. Clin. Cardiol. 1997; 20 (3): 200.
  14. Чернявский А. М., Рахмонов С. С., Пак И. А. и др. Результаты хирургического лечения фибрилляции предсердий методом эпикардиальной радиочастотной аблации анатомических зон ганглионарных сплетений левого предсердия во время аорто-коронарного шунтирования. Патология кровообращения и кардиохирургия. 2013; 2: 57–63.
  15. Ware J. E. Measuring patients' views: the optimum outcome measure. SF 36: a valid, reliable assessment of health from the patient's point of view. 1993; 306: 1429–1430.
  16. Гилеревский С. Р., Орлов В. А., Бенделиана Н. Г. и др. Изучение качества жизни с хронической сердечной недостаточностью: современное состояние проблемы. Рус. кардиол. журн. 2001; 3: 58–72.
  17. Jenkins L. S., Brodsky M, Schron E. et al. Quality of life in atrial fibrillation: the Atrial Fibrillation: the Follow-up Investigation of Rhythm Management (AFFIRM) study.Am Heart J., 2005; 149 (1): 112–120.
  18. Hohnloser S. H., Kuck K. H., Lilienthal J. Rhythm versus rate control in atrial fibrillation – Pharmacological intervention in atrial fibrillation (PIAF): a randomised trial. Lancet 2000; 356: 1789–94.
  19. Hagens V. E., Ranchor A. V., Van Sonderen E., et al. Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) study. J. Am. Coll. Cardiol. 2004; 43: 241–247.
Chernyavsky A. M., Rakhmonov S. S., Pak I. A. et al. Evaluation of quality of life in patients with ischemic heart disease associated with atrial fibrillation after radiofrequency ablation of anatomical areas in left atrial ganglionic plexi. Russian Heart Journal. 2015;14 (4):235–241

To access this material please log in or register

Register Authorize
Ru En